FDA Inspection 1205882 — Primera Analytical Solutions Corp.
The FDA completed an inspection of Primera Analytical Solutions Corp. on Oct 28, 2022 in Cranbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cranbury, NJ (United States)
Additional Details
Bioanalytical BA/BE